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GASTRIC CANCER
Fat transforms ascorbic acid from inhibiting to promoting
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Background: The major potential site of acid nitrosation is the proximal stomach, an anatomical site prone to
a rising incidence of metaplasia and adenocarcinoma. Nitrite, a pre-carcinogen present in saliva, can be
converted to nitrosating species and N-nitroso compounds by acidification at low gastric pH in the presence
of thiocyanate.
Aims: To assess the effect of lipid and ascorbic acid on the nitrosative chemistry under conditions simulating
the human proximal stomach.
Methods: The nitrosative chemistry was modelled in vitro by measuring the nitrosation of four secondary
amines under conditions simulating the proximal stomach. The N-nitrosamines formed were measured by gas
chromatography–ion-trap tandem mass spectrometry, while nitric oxide and oxygen levels were measured
amperometrically.
Results: In absence of lipid, nitrosative stress was inhibited by ascorbic acid through conversion of nitrosating
species to nitric oxide. Addition of ascorbic acid reduced the amount of N-nitrosodimethylamine formed by
fivefold, N-nitrosomorpholine by .1000-fold, and totally prevented the formation of N-nitrosodiethylamine
and N-nitrosopiperidine. In contrast, when 10% lipid was present, ascorbic acid increased the amount of N-
nitrosodimethylamine, N-nitrosodiethylamine and N-nitrosopiperidine formed by approximately 8-, 60- and
140-fold, respectively, compared with absence of ascorbic acid.
Conclusion: The presence of lipid converts ascorbic acid from inhibiting to promoting acid nitrosation. This
may be explained by nitric oxide, formed by ascorbic acid in the aqueous phase, being able to regenerate
nitrosating species by reacting with oxygen in the lipid phase.
O
ver the last 20 years, a new pattern of gastric carcino-
genesis has emerged in the western world, with a
decreasing incidence of distal gastric cancer and an
alarming increase in the incidence of adenocarcinomas of the
proximal stomach, including cardia and adjacent gastro-
oesophageal junction (GOJ).1–4 The cancers at the GOJ usually
occur in healthy acid-secreting stomachs.5 6 The cause of the
increasing incidence of adenocarcinoma of the proximal
stomach remains unclear, but the rate of change indicates
environmental factors.
For many years, there has been interest in the potential for
endogenous generation of carcinogenic N-nitroso compounds
from nitrite within the human upper gastrointestinal tract. This
is due to the fact that the acidic pH of gastric juice converts
nitrite to nitrous acid and nitrosating species such as N2O3,
NO+.7 8 The latter reacts with thiocyanate which is also present
in gastric juice to form the particularly potent nitrosating
species NOSCN.9–11 These nitrosating species can react with
secondary amines and amides to form N-nitroso compounds,
many of which are carcinogenic and widely used in animal
models of cancer.8 12–16 The nitrosating species N2O3 is itself
mutagenic as it can directly deaminate certain DNA bases and
inactivate important DNA repair enzymes.17–21 Understanding
the factors affecting gastric nitrite chemistry is therefore
relevant to our understanding the development of malignancies
of the upper stomach.
The main source of nitrite entering the stomach is swallowed
saliva. The high level of nitrite in saliva (100 mM under fasting
conditions) is derived from the enterosalivary recirculation of
dietary nitrate and its reduction to nitrite by buccal bacteria.22–27
Consequently, the nitrite level in saliva rises several fold for at
least 2 h after ingesting nitrate-containing foodstuffs. The nitrite
concentration in the distal oesophagus is similar to that in saliva.28
A major factor protecting against the generation of N-nitroso
compounds from salivary nitrite on entering the acidic stomach
is ascorbic acid present in gastric juice.29–33 Ascorbic acid is
actively secreted in gastric juice and effectively competes with
secondary amines and amides for reaction with the nitrosating
species.32 34–38 In this reaction, the nitrosating species are
reduced to nitric oxide and the ascorbic acid oxidised to
dehydroascorbic acid.39 We and others have recently demon-
strated that high concentrations of nitric oxide are generated in
the human upper gastrointestinal tract following nitrate intake
by the above mechanism.40
This reduction of acidified nitrite to nitric oxide has been
regarded as an effective mechanism for protecting against the
generation of N-nitroso compounds. However, it has recently
been recognised that nitric oxide can generate nitrosating
species. This arises from the ability of nitric oxide to react with
molecular oxygen to form N2O3 – the same species formed by
acidification of nitrite.18 41 42 The rate of the reaction between
nitric oxide and oxygen to produce N2O3 is proportional to the
concentration of oxygen and to the square of nitric oxide
concentration.43 44 Consequently, this reaction is most impor-
tant at high nitric oxide concentrations.
Recent studies have also demonstrated that the reaction
between nitric oxide and oxygen is 300 times faster within lipid
than within an aqueous phase.41 This is due to the fact that
nitric oxide is nine times more soluble in lipid, and oxygen is
also more soluble in lipid than aqueous solutions, resulting in
Abbreviations: GC-ITMS/MS, gas chromatography–ion-trap tandem
mass spectrometry; GOJ, gastro-oesophageal junction; NDEA, N-
nitrosodiethylamine; NDMA, N-nitrosodimethylamine; NMOR, N-
nitrosomorpholine; NPIP, N-nitrosopiperidine; PTV, programmable
temperature vaporising; TVC, total vitamin C
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both reactants accumulating in the lipid compartment.41 The
potential for generation of nitrosating species from nitric oxide
will therefore be greatest when high concentrations of nitric
oxide are generated close to lipids.
The above chemistry raises the possibility that inhibition of
nitrosation reactions by ascorbic acid in the aqueous phase may
promote nitrosation within adjacent lipid compartments. This
could occur by diffusion of the nitric oxide produced by the
reaction between acidified nitrite and ascorbic acid, into
adjacent lipid compartments and their reacting with oxygen
to form the nitrosating species N2O3. The presence of lipid
might therefore have a profound effect on the chemistry
occurring between acidified nitrite and ascorbic acid.
We have demonstrated that luminal nitrosative chemistry in
the acid-secreting stomach is maximal where swallowed saliva
first encounters acidic gastric juice and may therefore be
contributing to the high incidence of metaplasia and neoplasia
in the proximal stomach and GOJ.28 40 The aim of this study was
to investigate the influence of lipids on this luminal nitrosative
chemistry.
METHODS
Assay set-up
Studies were undertaken in a benchtop model representing the
GOJ, with and without lipid added to the acidic aqueous solution.
The aqueous phase (0.1 M HCl, pH 1.5) contained 1 mM EDTA,
1 mM sodium thiocyanate, and 5 mM of each secondary amine
(dimethylamine, diethylamine, morpholine, piperidine), in the
presence or absence of ascorbic acid (1 or 2 mM). The lipid phase
contained 5 mM of each secondary amine (dimethylamine,
diethylamine, morpholine and piperidine). Lipid (5 ml glycerol
trioctanoate, glycerol tributyrate or glycerol triacetate) was added
to give a ratio of aqueous to lipid of 10:1, as fat comprises 20–30%
of solid food ingested, and aqueous drinks along with aqueous
gastric juice will further reduce the fat content to approximately
10%. A low pH of 1.5 was used for the aqueous phase, as this has
been shown to be the postprandial pH of the cardia region of the
stomach.45 Both phases were combined and placed in a water bath
at 37˚ C and the aqueous phase was stirred with a magnetic stirrer.
The reaction was started by adding sodium nitrite (100 mM) to the
aqueous phase. The standard assay was carried out for a period of
15 min, after which N-nitrosamines were extracted from each
phase (aqueous and lipid).
Nitric oxide measurement
Nitric oxide dissolved in the aqueous phase was continuously
monitored using a nitric oxide electrode and meter (ISO NO
Mark II; World Precision Instruments, Sarasota, Florida, USA).
The nitric oxide electrode was calibrated by addition of sodium
nitrite at varying concentrations (10, 25, 50, 75 and 100 mM) to
simulated gastric juice (0.1 M HCl, pH 1.5, ascorbic acid
2 mM). Under these conditions, 1 mol nitrite yields 1 mol
nitric oxide. The nitric oxide meter was interfaced to a
computer, converting the electrical signal (pA) to nitric oxide
concentrations in mM; the response was linear for the range of
concentrations tested.
Oxygen measurement
Oxygen dissolved in the aqueous phase was continuously
monitored with an oxygen electrode and meter (Mark II; World
Precision Instruments). Electrode calibration was performed in
simulated gastric juice (0.1 M HCl, pH 1.5, ascorbic acid 2 mM)
according to the manufacturer’s instructions.
Nitrosamines extraction
A 1 ml aqueous phase aliquot was added to 0.5 ml 0.08 M HCl
and 5% sulphamic acid solution in saturated NaCl in a glass
tube, and mixed prior to the addition of 10 ml internal standard
(0.01% deuterated N-nitrosodimethylamine (NMDA)-d6 and
deuterated N-nitrosomorpholine (NMOR)-d8). The sample was
mixed well, and 0.5 ml extraction solvent mix (45:55 v/v
dichloromethane:diethyl-ether, 0.0025% butylhydroxytoluene)
was added. The sample was mixed and the upper layer was
transferred to a tapered vial. This step was repeated once more,
and the sample was concentrated to 100 ml under a gentle
stream of nitrogen, capped and stored at 220 C˚ until analysis.
A 0.5 ml lipid phase aliquot was added in a glass tube to 2 ml
88:12 hexane:ethyl acetate supplemented with 0.025% butylhy-
droxytoluene. The sample was mixed before addition of 10 ml
internal standard (0.01% deuterated NMDA and deuterated
NMOR). DSC-Diol solid-phase extraction cartridges (500 mg,
3 ml) were installed on a vacuum manifold (Phenomenex,
Macclesfield, UK) and equilibrated with 3 ml methanol, followed
by 2 ml 85:15 v/v ethyl acetate:methanol and 3 ml hexane. All
fractions were applied dropwise. The cartridges were washed
twice with 3 ml hexane, and dried under vacuum for 30 s. N-
Nitrosamines were eluted into 1.1 ml tapered vials (following the
addition of 0.5 ml elution solvents, 85:15 v/v ethyl acetate:metha-
nol), twice. A gentle vacuum was pulled through the cartridges for
30 s while the receiving vials remained in place. The samples were
concentrated down to 100 ml under a gentle stream of nitrogen,
capped and stored at 220˚ C until analysis.
Nitrosamines analysis
Nitrosamines analysis was carried out by gas chromatography–
ion-trap tandem mass spectrometry (GC-ITMS/MS) on a
TRACE GC 2000 Series gas chromatograph interfaced to a
Polaris Q ion-trap mass spectrometer equipped with an AS2000
autosampler and a programmable temperature vaporising
(PTV) injector (ThermoFinnigan, Hemel Hempsted, UK).
Nitrosamines (NDMA, N-nitrosodiethylamine (NDEA),
NMOR and N-nitrosopiperidine (NPIP)) were separated by
chromatography on a ZB-5MS fused-silica capillary column,
30 m60.25 mm internal diameter, 0.5 mm film thickness
(Phenomenex). The oven temperature programme was as
follows: 37 C˚ (held for 2 min) to 160 C˚ at 10 C˚/min, to 250 C˚
at 30 C˚/min (held for 2 min). Helium was used as a carrier gas
at a flow rate of 1 ml/min. The PTV injector was used in splitless
mode. The PTV temperature was programmed from 36 C˚ to
115 C˚ (held for 2 min) at 10 C˚/min and a pressure of 22 psi
(151 kPa), prior to a cleaning phase at 325 C˚ (held for 12 min).
Ion-trap tandem mass spectrometry was carried out by positive-
electron ionisation at an ionisation energy of 70 eV, with the ion
source temperature maintained at 220˚ C, and the transfer-line at
275˚ C. Acquisition was performed in three segments, segment 1
for NDMA and NDMA-d6 (start of acquisition at 4.5 min),
segment 2 for NDEA (start of acquisition at 7.3 min), and
segment 3 for NMOR, NMOR-d8 and NPIP (start of acquisition
at 10.9 min) with a trap offset voltage of +100 V on segment 3.
Precursor ions, excitation voltage and q values, as well as product
ions for each N-nitrosamine, are listed table 1.
Acquisition and treatment of GC-ITMS/MS data was per-
formed on Xcalibur version 2. All samples were spiked with
10 ml internal standard (0.01% deuterated NMDA and deuter-
ated NMOR), and GC-MS/MS spectra were calibrated with
spiked standard N-nitrosamines solutions covering concentra-
tions from 0 to 50 mM. Each calibration sample was extracted
according to the protocol used for assay samples, and the
response was linear for the concentrations studied.
Analysis of ascorbic acid/total vitamin C/
dehydroascorbic acid
The aqueous phase was sampled at t = 0, 1, 2, 5, 10 and 15 min
post addition of NaNO2 for ascorbic acid and total vitamin C
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(TVC) measurements. Sampling for TVC allows us to calculate
the amount of dehydroascorbic acid present by subtracting
ascorbic acid from TVC. The aqueous phase samples (100 ml)
were added to deionised water (900 ml). An aliquot of each
diluted sample (500 ml) was added to MS solution (500 ml, 2%
metaphosphoric acid/0.5% sulphamic acid, 1:1 v/v), while the
remainder (500 ml) was added to dithiothreitol/MS solution
(500 ml, 2% metaphosphoric acid/0.5% sulphamic acid, 1:1 v/v,
supplemented with 6 mg/ml dithiothreitol). The dithiothreitol
regenerates ascorbic acid from any dehydroascorbic acid for
ascorbic acid and TVC respectively. Ascorbic acid and TVC levels
were measured by high-performance liquid chromatography as
previously described46 based upon the method described by
Sanderson and Schorah.47
Reagents and chemicals
All solvents and reagents were obtained from Sigma Aldrich
(Poole, UK), except for the EDTA (BDH Ltd, Liverpool, UK) and
deuterated N-nitrosamine standards (Qmx laboratories,
Thaxted, UK). Solid-phase extraction cartridges were obtained
from Supelco (Poole, UK). Tapered vials were obtained from
Chromacol (Welwyn Garden City, UK).
Statistical analysis
Results are presented as mean values¡ SE. Statistical analysis
of all data was performed by ANOVA or Student’s t test. Tukey’s
HSD test was used for comparison of means within treatments.
Mean values were associated to symbols as an indication of
significance (p,0.001).
RESULTS
Nitrosation in aqueous solution without lipid present
In the absence of ascorbic acid
When nitrite was added to HCl pH 1.5 containing thiocyanate
(1 mM) without ascorbic acid, nitrosation of the secondary
amines was observed. After 15 min, 3.43¡0.12 mM NMOR was
preferentially formed, while only 0.02¡0.007 mM NDMA,
0.001¡0.000 mM and 0.002¡0.001 mM NPIP were detected
(table 2).
In these experiments, the addition of nitrite produced only a
very low concentration of nitric oxide (approximately 3.5 mM)
and no discernible fall in oxygen concentration.
In the presence of ascorbic acid
The presence of ascorbic acid markedly inhibited the nitrosation
of the secondary amines. The concentration of NDMA formed
was reduced by fivefold, while the concentration of NMOR
formed was reduced by more than a 1000-fold. NDEA and NPIP
were not detected (table 2). Addition of nitrite produced a rapid
increase in nitric oxide concentrations, followed by slow
decline. Within 60 s of sodium nitrite addition (100 mM), the
dissolved nitric oxide concentration was approximately 80 mM
(fig 1). This rapid rise in nitric oxide was accompanied by a
rapid fall in the dissolved oxygen concentration (fig 1). Within
60 s of sodium nitrite addition, no dissolved oxygen was
detected until 10 min later when the concentration slowly
increased to reach 5–10% of its original concentration.
The addition of nitrite (100 mM) triggered a fall in the
ascorbic acid concentration, from its original concentration of
970¡75 mM to 580¡40 mM at 2 min, and then it slowly fell to
480¡40 mM at 15 min (fig 2).
Table 1 GC-ITMS/MS ionisation conditions for analysis of
selected N-nitrosamines
Target
compound
Precursor ion
(m/z)
Product ion
(m/z)
Excitation
voltage
Excitation q
value
NDMA 74 44 0.85 0.45
NDMA-d6 80 50 0.85 0.45
NDEA 102 85 0.79 0.3
NMOR 116 86 0.63 0.3
NMOR-d8 124 94 0.63 0.3
NPIP 114 97 1 0.45
Table 2 N-nitrosamine concentrations (mM) in single and
dual-phase experiments 15 min after addition of nitrite
(100 mM) in presence or absence of ascorbic acid (2 mM)
(n = 12)
Aqueous phase only Aqueous phase + 10% lipid
2Ascorbic acid +Ascorbic acid 2Ascorbic acid +Ascorbic acid
Aqueous phase
NDMA 0.02¡0.01* 0.004¡0.003* 0.07¡0.02* 1.19¡0.13**
NDEA 0.001¡,0.001* ND 0.01¡0.003* 0.56¡0.07**
NMOR 3.43¡0.12* 0.003¡0.003** 3.37¡0.07* 0.75¡0.1***
NPIP 0.002¡0.001* ND 0.04¡0.002* 2.78¡0.92**
Lipid phase
NDMA 1.16¡0.27* 4.77¡0.4**
NDEA ND 1.18¡0.55**
NMOR ND 4.9¡0.41**
NPIP 0.06¡0.01* 29.3¡7.09**
For the same N-nitrosamine, concentrations on the same row followed by the same number of
asterix are not significantly different according to the Tukey’s HSD test (p,0.001).
ND not detected. Values are means ¡ SE.
Figure 2 Ascorbic acid (continuous line) and dehydroascorbic acid (dashed
line) concentrations in the aqueous phase after the addition of nitrite (100 mM)
to a dual-phase system containing ascorbic acid (1 mM) (n = 6).
Figure 1 Nitric oxide (continuous line) and oxygen (dashed line)
concentrations in the aqueous phase after the addition of nitrite (100 mM)
to a dual-phase system containing ascorbic acid (1 mM) (n = 6).
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Nitrosation in a dual-phase system containing aqueous
solution and 10% lipid
In absence of ascorbic acid
When nitrite was added to HCl pH 1.5 containing thiocyanate
(1 mM), no ascorbic acid and 10% lipid, nitrosation of the
secondary amines was observed. The concentrations of N-
nitrosamines formed in the aqueous phase were similar to
those observed in the absence of lipid, with NMOR preferen-
tially formed (3.37¡0.07 mM) (table 2). Only NDMA
(1.16¡0.27 mM) and NPIP (0.06¡0.01 mM) were detected in
the lipid phase (table 2).
In presence of ascorbic acid
In marked contrast to the observations in the absence of lipid,
the addition of ascorbic acid did not inhibit the generation of N-
nitrosamines in the presence of 10% lipid. Indeed, in the
presence of lipid and ascorbic acid, substantial concentrations
of each of the N-nitrosamines were detected in both the
aqueous and lipid phases (table 2). After 15 min, the
concentrations of each N-nitrosamine in the lipid phase, and
the concentration of NDMA, NDEA and NPIP in the aqueous
phase, were significantly higher than in the absence of ascorbic
acid (p,0.001). In the aqueous phase, 1.19¡0.13 mM NDMA,
0.56¡0.07 mM NDEA, 0.74¡0.1 mM NMOR and
2.78¡0.92 mM NPIP were detected. In the lipid phase,
4.77¡0.4 mM NDMA, 1.18¡0.55 mM NDEA, 4.90¡0.41 mM
NMOR and 29.3¡7.01 mM NPIP were detected (table 2). In the
presence of lipid, the addition of nitrite produced similar
changes in the concentrations of nitric oxide, oxygen and
ascorbic acid to those seen in the absence of lipid.
Effect of the lipid on the influence of ascorbic acid on acid
nitrosation
The presence of lipid transformed the overall effect of ascorbic acid
from inhibiting to promoting N-nitrosamine formation. In the
absence of lipid, ascorbic acid totally inhibited the formation of
NDEA and NPIP, and reduced the formation of NDMA by fivefold
and NMOR by more than a 1000-fold. The addition of lipid to the
system, in a 1:10 ratio, overrode the protective effect of ascorbic
acid. In the presence of lipid, the addition of ascorbic acid
increased the amount of three of the N-nitrosamines in the dual-
phase system: NDMA by approximately eightfold, from
4.7¡0.77 nmol to 39.19¡3.49 nmol; NDEA by approximately
60-fold, from 0.3¡0.08 nmol to 18.13¡1.98 nmol, and NPIP by
approximately 140-fold, from 1.05¡0.07 nmol to
147.35¡31.59 nmol (fig 3). In the presence of lipid, the addition
of ascorbic acid reduced the total amount of NMOR in the system
by approximately threefold, from 84.21¡1.78 nmol to
28.78¡2.59 nmol (fig 3), levels that were nonetheless signifi-
cantly higher than in the presence of ascorbic acid and absence of
lipid (0.08¡0.08 nmol) (p,0.001). In addition, ascorbic acid
increased the concentration of NMOR formed in the lipid from
undetectable to 4.9¡0.4 mM (p,0.001).
Variations in the nature of the lipid phase
The conversion of the inhibiting effect of ascorbic acid on
nitrosation to a promoting effect was observed with three
different lipid phases (glycerol trioctanoate, a low-density lipid,
and glycerol tributyrate and glycerol triacetate, two high-
density lipids). While glycerol trioctanoate provided a physio-
logically accurate representation of a floating lipid layer,
glycerol tributyrate and glycerol triacetate were included in
the study in order to test the robustness of our benchtop system
when lipids are not in direct contact with air. Each of the three
lipids generated similar results (data not shown).
Time course study of N-nitrosamines diffusion in a dual-
phase system
Diffusion of the four N-nitrosamines from the lipid phase to the
acidic aqueous phase under conditions similar to the previous
experiment (0.1 M HCl, pH 1.5, at 37 C˚, in the presence of
EDTA, thiocyanate and ascorbic acid) was monitored by adding
10 mM each N-nitrosamine to the lipid phase at t = 0, and
measuring their concentration in each phase during a 60 min
time course. The concentrations of all four N-nitrosamines
decreased in the lipid phase and increased in the aqueous phase
over time (60 min) (table 3). The total N-nitrosamine concen-
tration of the lipid phase decreased from 40 mM down to
approximately 12 mM, while the total N-nitrosamine concen-
tration in the aqueous phase rose to approximately 2.6 mM
(fig 4). The diffusion pattern of all four N-nitrosamines was
comparable, although NPIP tended to remain at higher levels in
the lipid phase (table 3).
DISCUSSION
These studies indicate that the presence of lipid profoundly
alters acid-catalysed nitrosative chemistry. The lipid phase is
able to convert the influence of ascorbic acid from one that
protects against nitrosation to one that promotes it. This effect
is likely to be due to the ability of the nitric oxide formed by
ascorbic acid within the aqueous phase to regenerate nitrosative
species by reacting with oxygen within the lipid phase.
In the studies performed without lipid, and without ascorbic
acid, the addition of nitrite to the HCl pH 1.5 containing
thiocyanate resulted in nitrosation of the secondary amines.
The main nitrosating species formed under these conditions is
NOSCN.9–11 NOSCN reacts with the secondary amine in its
unprotonated uncharged state.48 The amount of the secondary
amine in its nitrosatable form depends upon its 2log
 
Figure 3 N-nitrosamines present in the single and dual-phase systems in
the presence and absence of ascorbic acid (2 mM) 15 min after addition of
nitrite (100 mM) (n = 12).
Figure 4 Diffusion of total N-nitrosamines in a dual-phase system. N-
nitrosamine concentration in the lipid phase (square), N-nitrosamine
concentration in the aqueous phase (triangle) (n = 12).
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dissociation constant (pKa). The pKa values of the amines studied
are 8.33 for morpholine, 11.22 for piperidine, 10.73 for dimethya-
mine and 11.09 for diethylamine. The amount of the secondary
amine in a form available for nitrosation by NOSCN will therefore
be greatest for morpholine and least for piperidine. The differences
in pKa can partially explain why different concentrations of the
four N-nitrosamines were generated.
In the experiments performed in the absence of lipid, the
addition of ascorbic acid effectively prevented the nitrosation of
the amines. This can be explained by the ascorbic acid
competing with the secondary amines for the NOSCN.36 38 49
In the reaction between ascorbic acid and NOSCN, the latter is
reduced to nitric oxide and the former oxidised to dehydroas-
corbic acid. Consistent with this, we observed a burst of nitric
oxide accompanied by a fall in the ascorbic acid and oxygen
concentrations. This can be explained by the nitric oxide
reacting with dissolved oxygen to form N2O3.
43 44 The N2O3
formed in this way is a nitrosating species and again
preferentially reacts with ascorbic acid and is reduced back to
nitric oxide.39 This recycling continues until either the oxygen or
the ascorbic acid is consumed. Under our experimental
conditions, the oxygen was the first to be depleted.
Stoichemically, 1 mol ascorbic acid can reduce 2 mol nitrite to
nitric oxide. The greater consumption of ascorbic acid observed
is due to this recycling of nitric oxide.
In the presence of the lipid, N-nitrosamines were formed
despite the presence of ascorbic acid. Indeed, the presence of
lipid transformed the effect of the ascorbic acid from effectively
inhibiting nitrosation of each amine to powerfully enhancing
nitrosation of three of the four amines. (The overall amounts of
NDMA, NDEA and NPIP in the system were increased by 8-, 60-
and 140-fold, respectively, in the dual-phase system when
ascorbic acid was present versus absent; fig 3.) The overall
amount of NMOR formation was inhibited by ascorbic acid in
both the absence and presence of lipid, although the inhibitory
effect of ascorbic acid was markedly reduced by the presence of
lipid, from over 1000-fold in absence of lipid, to only threefold
in the presence of lipids. In addition, the presence of ascorbic
acid increased the concentration of NMOR in the lipid from
undetectable to 4.9¡0.4 mM.
What is the explanation for the ability of the lipid to convert
the effect of the ascorbic acid from being an inhibitor to a
promoter of nitrosation? The effect observed is likely to be
mediated by the nitric oxide produced by the reaction between
the ascorbic acid and the nitrosating species within the aqueous
phase. The nitric oxide will diffuse into to the lipid phase and
within it react with oxygen to form N2O3.
50 Liu et al.
demonstrated that the reaction between nitric oxide and
oxygen is 300 times faster in lipid than in aqueous solutions,
due to the increased solubility of both gases in lipids.41 As
ascorbic acid is not lipophilic, it is unable to enter the lipid and
thus the N2O3 generated within the lipid will be able to
nitrosate the secondary amines within the lipid. The N-
nitrosamines generated within the lipid in this way will then
diffuse out of the lipid and produce the rise in their
concentration observed in the aqueous compartment (fig 5).
In the dual-phase studies without ascorbic acid, low concentra-
tions of NDMA and NPIP were detected in the lipid phase,
whereas NDEA and NMOR were both undetectable in the lipid
phase. NDMA and NPIP are more lipid soluble than NMOR (ClogP
0.01, 0.73 and 20.33, respectively) and are likely to have diffused
into the lipid following their generation in the aqueous phase. Low
levels of nitric oxide are present in the aqueous phase even in the
absence of ascorbic acid and this may also have nitrosated
dimethylamine and piperidine within the lipid phase. The dual-
phase experiments with ascorbic acid indicated that dimethyla-
mine and piperidine were the amines most nitrosated by nitric
oxide in the lipid phase. Piperidine showed the greatest degree of
nitrosation in the dual phase; this may be due to its lipophilicity
(ClogP 0.52) and thus it is the one most available for nitrosation
within the lipid compartment.51
In the dual-phase system, the concentrations of three of the
N-nitrosamines detected in the aqueous phase were signifi-
cantly greater in the presence versus absence of ascorbic acid.
The one exception was NMOR and a number of factors may
explain this. First, the amount of NMOR formed in the aqueous
phase in the absence of ascorbic acid is considerably greater
than the amount of other N-nitrosamines, due to its lower pKa
and thus higher proportion in the nitrosatable unprotonated
form.52 Second, the aqueous concentrations of each N-nitrosa-
mine were similar in presence of both ascorbic acid and lipid
compared to aqueous concentrations in the absence of ascorbic
acid (table 2). This is because the N-nitrosamines detected in
the aqueous phase in presence of both ascorbic acid and lipid
Figure 5 Proposed mechanism of N-nitrosamine formation in a dual-
phase system with ascorbic acid present in the aqueous phase. Nitrite
forms nitrous acid and nitrosating species in the acidic aqueous
environment. In the presence of ascorbic acid (ASC), the nitrosating species
are reduced to nitric oxide which diffuses into the lipid where it reacts with
oxygen reforming nitrosating species such as N2O3. Ascorbic acid is
reduced to dehydroascorbic acid. Secondary amines present within the
lipid are nitrosated by N2O3 to form N-nitrosamines. The latter then diffuse
back to the aqueous phase.
Table 3 Time course study of standard N-nitrosamine
concentration in a dual-phase system (n = 12)
Standard N-
nitrosamine
Concentration (mM)
5 min 15 min 30 min 45 min 60 min
Aqueous phase
NDMA 0.15¡0.01 0.29¡0.06 0.40¡0.04 0.48¡0.07 0.54¡0.01
NDEA 0.08¡0.01 0.18¡0.02 0.3¡0.01 0.49¡0.15 0.64¡0.02
NMOR 0.09¡0.02 0.25¡0.07 0.33¡0.03 0.89¡0.28 0.70¡0.01
NPIP 0.09¡0.01 0.09¡0.03 0.34¡0.03 0.68¡0.08 0.75¡0.1
Lipid phase
NDMA 6.64¡0.40 4.03¡0.25 1.97¡0.24 0.86¡0.24 0.39¡0.01
NDEA 6.29¡0.48 5.11¡0.67 5.86¡1.74 4.61¡1.51 2.98¡0.67
NMOR 10.62¡0.61 8.75¡0.51 5.86¡0.24 3.71¡0.12 2.96¡0.20
NPIP 13.34¡0.73 9.75¡0.9 8.95¡0.57 6.49¡0.4 5.69¡0.20
10 mM of each N-nitrosamine was added to the lipid phase at time 0 min, and concentrations in
each phase were monitored over the subsequent 60 min.
Values are means ¡ SE.
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will have been formed mainly in the lipid phase, where the pKa
of the amine is not relevant. The decrease of NMOR aqueous
concentration in the dual-phase system in presence of ascorbic
acid compared to when ascorbic acid is absent is therefore
mainly explained by the inhibition of the aqueous nitrosation of
morpholine when ascorbic acid is present. In addition,
differences in partitioning of the different amines and N-
nitrosamines between the lipid and aqueous phase may
contribute to the different results.
The above studies indicate that the presence of lipid
transforms the regulation of nitrosative chemistry in conditions
simulating the proximal stomach. The presence of lipid over-
comes the protective effect of ascorbic acid and indeed
transforms ascorbic acid from an inhibitor to a promoter of
nitrosation. The transforming role of lipids is likely to be
relevant to the in vivo situation as lipid is present in the
proximal stomach for a considerable time after eating and is
also an important component of the epithelial membranes.
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Haematemesis with mediastinal lymphadenopathy
Clinical presentation
A 33-year-old previously well man presented with sudden
haematemesis and mild epigastric tenderness. At endoscopy,
bleeding from a ‘‘ragged’’ lesion at the gastro-oesophageal
junction was noted and biopsy samples were taken. Follow-up
gastroscopy showed a 3 cm submucosal mass (fig 1). A
computed tomography (CT) scan confirmed the presence of a
soft tissue mass arising from the gastro-oesophageal junction
extending into the gastric lumen and also showed hilar and
mediastinal lymphadenopathy and bilateral, predominantly
mid-zone, nodular shadowing (fig 2).
The patient later developed epigastric discomfort, nausea,
exertional dyspnoea and cervical lymphadenopathy. Figure 3
shows the histopathology of the specimen taken from the
gastro-oesophageal junction.
Questions
What was the cause of this patient’s gastrointestinal bleed?
What is the diagnosis?
See page 1695 for answers
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Figure 1 Endoscopic appearance of gastro-oesophageal mass.
Figure 2 CT appearance of gastro-oesophageal mass.
Figure 3 Microscopic appearance of biopsy samples from the gastro-
oesophageal junction.
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